ASCO 2014: Dr. Susan O'Brien Outlines Open Tri... - CLL Support

CLL Support

23,138 members39,744 posts

ASCO 2014: Dr. Susan O'Brien Outlines Open Trials of Novel Agents and Equipoise in Trial Design for CLL

bkoffman profile image
bkoffmanCLL CURE Hero
4 Replies

This is important stuff on my blog, bkoffman.blogspot.com, a strong argument to consider a clinical trial and an even stronger push to make sure it is ethically designed.

Written by
bkoffman profile image
bkoffman
CLL CURE Hero
To view profiles and participate in discussions please or .
Read more about...
4 Replies
AussieNeil profile image
AussieNeilPartnerAdministrator

Plenty of good info in your latest blog Brian, supported by very useful reference links. And thanks for dropping the brackets around your blog link; it's a pleasant surprise not to have to edit your post :) .

Neil

PaulaS profile image
PaulaSVolunteer

Thanks Brian, very interesting. And I have to ask - did you arrive in time for your rental car? :-)

Paula

bkoffman profile image
bkoffmanCLL CURE Hero in reply to PaulaS

Sure did. Turns out they are open until 1:30 AM but the website said midnight. I traveled coast to coast and was home in < 30 hours.

PaulaS profile image
PaulaSVolunteer in reply to bkoffman

That's great. I'm really glad to hear that.

Not what you're looking for?

You may also like...

ASCO 2014: Dr. Susan O'Brien Reviews the 3 years follow-up Data on Ibrutinib in CLL

Friends, I am stuck at the airport on my way to OSU waiting for my delayed flight, so I thought I...

Revisiting Richter transformation in the era of novel CLL agents

September 2021 A thorough review of where we are with the understanding and treatment of Richter's....

Dr. O'Brien on Trial Design, CT scans and the one and only place for FCR.

Friends, Please check out my blog: http://bkoffman.blogspot.com to hear my last interview from...

ASCO 2016: Dr. Susan O’Brien where she discusses frontline data on Acalabrutinib in CLL

We are 8 weeks out from the 2016 annual meeting of the American Society of Hematology and realize...

Chemotherapy vs Ibrutinib for CLL Frontline Treatment - Dr Susan O'Brien. 12 to 24% of FCR patients effectively cured 6 years after FCR

Anyone interested in the pros and cons of chemotherapy vs non-chemotherapy treatment should watch...